{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:57:28Z","timestamp":1790672248548,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["healthpolicyjrnl.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Health Policy"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.healthpol.2014.10.007","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T16:00:26Z","timestamp":1413993626000},"page":"195-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["A comparative study of the role of disease severity in drug reimbursement decision making in four European countries"],"prefix":"10.1016","volume":"119","author":[{"given":"Margreet","family":"Franken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Scharringhausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthonius","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Koopmanschap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healthpol.2014.10.007_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.healthpol.2012.09.012","article-title":"Commonalities and differences in HTA outcomes: a comparative analysis of five countries and implications for coverage decisions","volume":"108","author":"Nicod","year":"2012","journal-title":"Health Policy"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/(SICI)1099-1050(199902)8:1<25::AID-HEC398>3.0.CO;2-H","article-title":"Incorporating societal concerns for fairness in numerical valuations of health programmes","volume":"8","author":"Nord","year":"1999","journal-title":"Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0015","series-title":"The relative societal value of health gains to different beneficiaries","author":"Dolan","year":"2008"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0020","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1017\/S0266462312000529","article-title":"European drug reimbursement systems\u2019 legitimacy: five-country comparison and policy tool","volume":"28","author":"Cleemput","year":"2012","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1017\/S0266462312000530","article-title":"Similarities and differences between five European drug reimbursement systems","volume":"28","author":"Franken","year":"2012","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0030","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.healthpol.2005.01.018","article-title":"Equity in health care prioritisation: an empirical inquiry into social value","volume":"74","author":"Stolk","year":"2005","journal-title":"Health Policy"},{"issue":"6","key":"10.1016\/j.healthpol.2014.10.007_bib0035","first-page":"63","article-title":"Identification of health baskets in nine EU countries","volume":"6\u20137","author":"Velasco-Garrido","year":"2006","journal-title":"La Doc. fran\u00e7aise: Revue fran\u00e7aise des affaires sociales"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.healthpol.2014.02.009","article-title":"Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY","volume":"116","author":"Nord","year":"2014","journal-title":"Health Policy"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0045","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/14737167.1.1.85","article-title":"Severity of illness versus expected benefit in societal evaluation of healthcare interventions","volume":"1","author":"Nord","year":"2001","journal-title":"Expert Review of Pharmacoeconomics and Outcomes Research"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.healthpol.2009.08.005","article-title":"Severity of illness and priority setting in healthcare: a review of the literature","volume":"93","author":"Shah","year":"2009","journal-title":"Health Policy"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0055","series-title":"Drug reimbursement systems: international comparison and policy recommendations","author":"le Polain","year":"2010"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s40273-013-0030-0","article-title":"Decision-makers\u2019 preferences for approving new medicines in Wales: a discrete-choice experiment with assessment of external validity","volume":"31","author":"Linley","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0065","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1017\/S0266462310000048","article-title":"Have you made up your mind? A discrete choice experiment","volume":"26","author":"Koopmanschap","year":"2010","journal-title":"International Journal of Technology Assessment in Health Care"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0070","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1002\/hec.2872","article-title":"Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults in Great Britain","volume":"22","author":"Linley","year":"2013","journal-title":"Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0075","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1524-4733.2010.00781.x","article-title":"Willingness to pay for a quality-adjusted life-year: the individual perspective","volume":"13","author":"Bobinac","year":"2010","journal-title":"Value in Health"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0080","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jhealeco.2011.01.003","article-title":"Deriving distributional weights for QALYs through discrete choice experiments","volume":"30","author":"Lancsar","year":"2011","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0085","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.socscimed.2009.03.020","article-title":"Investigating public preferences on \u2018severity of health\u2019as a relevant condition for setting healthcare priorities","volume":"68","author":"Green","year":"2009","journal-title":"Social Science and Medicine"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0090","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10198-010-0249-z","article-title":"Severity as an independent determinant of the social value of a health service","volume":"12","author":"Richardson","year":"2011","journal-title":"The European Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10198-013-0482-3","article-title":"Valuing health at the end of life: an empirical study of public preferences","volume":"15","author":"Shah","year":"2014","journal-title":"European Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jval.2013.06.002","article-title":"Priority preferences: end of Life does not matter, but total life does","volume":"16","author":"Olsen","year":"2013","journal-title":"Value in Health"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0105","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/jme.2007.021790","article-title":"Public healthcare resource allocation and the rule of rescue","volume":"34","author":"Cookson","year":"2008","journal-title":"Journal of Medical Ethics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0110","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/jme.26.5.323","article-title":"Principles of justice in health care rationing","volume":"26","author":"Cookson","year":"2000","journal-title":"Journal of Medical Ethics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0115","series-title":"A call to make valuable innovative medicines available in the European Union. Recommendations for a coordinated action to stimulate, measure, and valorise pharmaceutical innovation","author":"Annemans","year":"2010"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B","article-title":"Intergenerational equity: an exploration of the \u2018fair innings\u2019 argument","volume":"6","author":"Williams","year":"1997","journal-title":"Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0125","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.socscimed.2004.05.003","article-title":"Concerns for the worse off: fair innings versus severity","volume":"60","author":"Nord","year":"2005","journal-title":"Social Science and Medicine"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0130","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1586\/14737167.1.1.85","article-title":"Severity of illness versus expected benefit in societal evaluation of healthcare interventions","volume":"1","author":"Nord","year":"2001","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0135","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/00019053-200422170-00001","article-title":"Reconciliation of economic concerns and health policy","volume":"22","author":"Stolk","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0140","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/S0277-9536(02)00244-7","article-title":"The rule of rescue","volume":"56","author":"McKie","year":"2003","journal-title":"Social Science and Medicine"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s40273-013-0074-1","article-title":"Unravelling drug reimbursement outcomes: a comparative study of the role of pharmacoeconomic evidence in Dutch and Swedish reimbursement decision-making","volume":"31","author":"Franken","year":"2013","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0150","series-title":"Management of the basic benefit package in practice 2","author":"Zwaap","year":"2009"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10198-011-0346-7","article-title":"Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall","volume":"14","author":"Van de Wetering","year":"2013","journal-title":"The European Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0160","first-page":"1","article-title":"Health system review","volume":"12","author":"Gerkens","year":"2010","journal-title":"Health Systems in Transition"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0165","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S1744133107004082","article-title":"Implementing accountability for reasonableness\u2014the case of pharmaceutical reimbursement in Sweden","volume":"2","author":"Jansson","year":"2007","journal-title":"Health Economics, Policy and Law"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0170","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10198-010-0284-9","article-title":"French approach to cost-effectiveness analysis","volume":"11","author":"de Pouvourville","year":"2010","journal-title":"The European Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0175","first-page":"59","article-title":"Le r\u00f4le de la commission de la transparence de la HAS dans la pertinence de l\u2019admission au remboursement des m\u00e9dicaments par l\u2019assurance maladie","volume":"44","author":"Bouvenot","year":"2013","journal-title":"Regards: Protection Sociale"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0180","unstructured":"Pharmaceutical Policy and Management Unit Global analytical report on the content of Pharmanet - singular pathway. Brussel: National Institute for Health and Disability Insurance; 2009;1\u201380 [Available at: http:\/\/www.inami.fgov.be\/drug\/fr\/statistics-scientific-information\/pharmanet\/introduction\/pdf\/analyticalreport_eng.pdf]."},{"key":"10.1016\/j.healthpol.2014.10.007_bib0185","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1088-4963.1997.tb00082.x","article-title":"Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers","volume":"26","author":"Daniels","year":"1997","journal-title":"Philosophy & Public Affairs"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0190","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jhealeco.2004.11.007","article-title":"Health priorities and public preferences: the relative importance of past health experience and future health prospects","volume":"24","author":"Dolan","year":"2005","journal-title":"Journal of Health Economics"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0195","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1215\/03616878-2373166","article-title":"Can the NICE end-of-life premium be given a coherent ethical justification?","volume":"38","author":"Cookson","year":"2013","journal-title":"Journal of Health Politics, Policy and Law"},{"key":"10.1016\/j.healthpol.2014.10.007_bib0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jhealeco.2010.03.010","article-title":"Increasing marginal utility of small increases in life-expectancy results from a population survey","volume":"29","author":"Kvamme","year":"2010","journal-title":"Journal of Health Economics"}],"container-title":["Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851014002711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168851014002711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T10:08:47Z","timestamp":1565950127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168851014002711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0168851014002711"],"URL":"https:\/\/doi.org\/10.1016\/j.healthpol.2014.10.007","relation":{},"ISSN":["0168-8510"],"issn-type":[{"value":"0168-8510","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparative study of the role of disease severity in drug reimbursement decision making in four European countries","name":"articletitle","label":"Article Title"},{"value":"Health Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healthpol.2014.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}